STAGE IIIC LUNG CANCER AJCC V8
Clinical trials for STAGE IIIC LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIC LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising cancer combo trial halted early
Disease control TerminatedThis study tested a new drug (BMS-986218) plus nivolumab and targeted radiation in people with advanced solid tumors that had spread. The goal was to see if this combination could help the immune system fight cancer better. Only 13 people took part before the study was stopped ea…
Matched conditions: STAGE IIIC LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Experimental cocktail aims to reboot immune attack on tough cancers
Disease control TerminatedThis early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combo could shrink tumors or con…
Matched conditions: STAGE IIIC LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Lung cancer combo trial halted early – what we know
Disease control TerminatedThis study tested whether adding the immunotherapy drug bintrafusp alfa to standard chemotherapy (docetaxel) could help people with advanced non-small cell lung cancer whose disease had worsened after prior treatment. Only 10 participants were enrolled before the trial was stoppe…
Matched conditions: STAGE IIIC LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC